ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Effects of dihydroartemisinin, a metabolite of artemisinin, on colon cancer chemoprevention and adaptive immune regulation

Wang, Chong-Zhi*; Wan, Chunping; Luo, Yun; Zhang, Chun-Feng; Zhang, Qi-Hui; Chen, Lina; Liu, Zhi; Wang, Daniel H.; Lager, Mallory; Li, Cang-Hai; Jiang, Ting-Liang; Hou, Lifei; Yuan, Chun-Su重庆大学; 1
Molecular Biology Reports2022-4DOI: 10.1007/s11033-021-07079-1
6被引10阅读
引用收藏
分享

摘要

Background Artemisinin (ART) is an anti-malaria natural compound with a moderate anticancer action. As a metabolite of ART, dihydroartemisinin (DHA) may have stronger anti-colorectal cancer (CRC) bioactivities. However, the effects of DHA and ART on CRC chemoprevention, including adaptive immune regulation, have not been systematically evaluated and compared. Methods Coupled with a newly-established HPLC analytical method, enteric microbiome biotransformation was conducted to identify if the DHA is a gut microbial metabolite of ART. The anti-CRC potential of these compounds was compared using two different human CRC cell lines for cell cycle arrest, apoptotic induction, and anti-inflammation activities. Naive CD4(+) T cells were also obtained for testing the compounds on the differentiation of Treg, Th1 and Th17. Results Using compound extraction and analytical methods, we observed for the first time that ART completely converted into its metabolites by gut microbiome within 24 h, but no DHA was detected. Although ART did not obviously influence cancer cell growth in the concentration tested, DHA very significantly inhibited the cancer cell growth at relatively low concentrations. DHA included G2/M cell cycle arrest via upregulation of cyclin A and apoptosis. Both ART and DHA downregulated the pro-inflammatory cytokine expression. The DHA significantly promoted Treg cell proliferation, while both ART and DHA inhibited Th1 and Th17 cell differentiation. Conclusions As a metabolite of ART, DHA possessed stronger anti-CRC activities. The DHA significantly inhibited cell growth via cell cycle arrest, apoptosis induction and anti-inflammation actions. The adaptive immune regulation is a related mechanism of actions for the observed effects.

学科与关键词

关键词
DihydroartemisininArtemisininCell cycle and apoptosisColorectal cancerT helper 17 cellsAnti-inflammation and adaptive immunity
相关
加载中…
  • Ruthenium-dihydroartemisinin complex: a promising new compound for colon cancer prevention via G1 cell cycle arrest, apoptotic induction, and adaptive immune regulation
    Wang, Chong-Zhi*; Wan, Chunping; Li, Cang-Hai; Liang, Guo-Gang; Luo, Yun; Zhang, Chun-Feng; Zhang, Qi-Hui; Ma, Qinge; Wang, Angela H.; Lager, Mallory; Jiang, Ting-Liang; Hou, Lifei; Yuan, Chun-SuCancer Chemotherapy and Pharmacology, 2024.
  • Dihydroartemisinin (DHA) induces caspase-3-dependent apoptosis in human lung adenocarcinoma ASTC-a-1 cells
    Lu Y Y; Chen T S; Qu J L; Pan W L; Sun L; Wei X B*Journal of Biomedical Science, 2009, 16(1).
  • Dihydroartemisinin inhibits activation of the AIM2 inflammasome pathway and NF-κB/HIF-1α/VEGF pathway by inducing autophagy in A431 human cutaneous squamous cell carcinoma cells
    Wang, Yajie; Li, Zhijia; Teng, Muzhou*; Liu, Junlin*International Journal of Medical Sciences, 2021, 18(12): 2705-2715.被引 9
查看全部 →

发表信息

论文状态
公开发表
期刊
Molecular Biology Reports
发表日期
2022-04
卷期
第 49 卷, 第 4 期
页码
2695-2709
DOI
10.1007/s11033-021-07079-1
语言
ENGLISH
期刊等级
4区
成果收录
SCIE
资助标注
NIH/NCCAM [P01 AT004418, K01 AT005362, 5P30DK042086]

作者

  • W

    Wang, Chong-Zhi (通讯) (第一作者)

    1 · yunnan univ tradit chinese med

  • W

    Wan, Chunping

    1 · yunnan univ tradit chinese med

查看全部 13 位作者收起作者
  • L

    Luo, Yun

  • Z

    Zhang, Chun-Feng

    china pharmaceut univ

  • Z

    Zhang, Qi-Hui

    chongqing univ

  • C

    Chen, Lina

    nanjing med univ

  • L

    Liu, Zhi

  • W

    Wang, Daniel H.

  • L

    Lager, Mallory

  • L

    Li, Cang-Hai

  • J

    Jiang, Ting-Liang

  • H

    Hou, Lifei

  • Y

    Yuan, Chun-Su

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417